Literature DB >> 9160342

Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis.

C Schiepers1, P Van Hecke, R Vandenberghe, S Van Oostende, P Dupont, P Demaerel, G Bormans, H Carton.   

Abstract

OBJECTIVE: To assess characteristics of MS lesions and normal appearing white matter (NAWM) with various imaging modalities. Glucose metabolism was investigated with FDG-PET, metabolite concentration with proton NMR spectroscopy, and lesion detection with routine brain MRI.
METHODS: Thirteen patients were studied in a stable phase of their disease, and two during an acute episode. Nine healthy volunteers served as controls.
RESULTS: Three patients had a normal brain MRI, 12 had typical lesions. MR images were registered to the PET planes. Lesions and contra-lateral control areas were analyzed, 10/15 lesions showed relative hyper-metabolism and 2 hypo-metabolism. NAA concentration was significantly decreased in both lesions and NAWM.
CONCLUSION: In stable MS, most large lesions have a relatively increased glucose utilization and decreased NAA concentration. NAWM showed a significantly decreased NAA concentration compared to healthy subjects, but no difference in glucose metabolism. Active lesions in acute MS are also hyper-metabolic. This finding opens a new window on the classification of white matter lesions based on glucose utilization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160342     DOI: 10.1177/135245859700300102

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  25 in total

1.  In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.

Authors:  Abraham Martín; Nuria Vázquez-Villoldo; Vanessa Gómez-Vallejo; Daniel Padro; Federico N Soria; Boguslaw Szczupak; Sandra Plaza-García; Ander Arrieta; Torsten Reese; Jordi Llop; Maria Domercq; Carlos Matute
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-10       Impact factor: 9.236

2.  Poster Viewing Sessions PA00-A01 to PA00-A49.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

Review 3.  Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials.

Authors:  Maria Pia Sormani; Matteo Pardini
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 4.  11C-methionine PET/CT findings in benign brain disease.

Authors:  Reiko Nakajima; Ken Kimura; Koichiro Abe; Shuji Sakai
Journal:  Jpn J Radiol       Date:  2017-04-18       Impact factor: 2.374

Review 5.  PET imaging in multiple sclerosis.

Authors:  Daniele de Paula Faria; Sjef Copray; Carlos Buchpiguel; Rudi Dierckx; Erik de Vries
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-09       Impact factor: 4.147

6.  Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study.

Authors:  I Mader; W Roser; L Kappos; G Hagberg; J Seelig; E W Radue; W Steinbrich
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

7.  Axonal damage in multiple sclerosis.

Authors:  Jeffery D Haines; Matilde Inglese; Patrizia Casaccia
Journal:  Mt Sinai J Med       Date:  2011 Mar-Apr

8.  Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: implications for understanding the pathogenesis of multiple sclerosis and consolidation of quantitative MRI results in MS.

Authors:  Khader M Hasan; Indika S Walimuni; Humaira Abid; Sushmita Datta; Jerry S Wolinsky; Ponnada A Narayana
Journal:  J Neurol Sci       Date:  2011-10-05       Impact factor: 3.181

9.  Proton MR spectroscopy in neuroborreliosis: a preliminary study.

Authors:  A Ustymowicz; E Tarasów; J Zajkowska; J Walecki; T Hermanowska-Szpakowicz
Journal:  Neuroradiology       Date:  2003-12-09       Impact factor: 2.804

10.  Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.

Authors:  Elfar Adalsteinsson; Annette Langer-Gould; Ronald J Homer; Archana Rao; Edith V Sullivan; Christiane Abbehusen Lima; Adolf Pfefferbaum; Scott W Atlas
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.